refractory Non-Hodgkin's lymphoma

refractory Non-Hodgkin's lymphoma is the indication for 5 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as: NonHodgkin's Lymphoma Refractory · Non-Hodgkin Lymphoma, Refractory
Classified under: Hemic and Lymphatic Diseases
Immune System Diseases
Neoplasms
Indicated drugs: Carboplatin
Carmustine
Fludarabine
Methotrexate
Pixantrone

Resolves to

Vocabularies

MedDRA10029595UMLSC0854867

What you can answer from here — as of October 06, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

138Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for refractory Non-Hodgkin's lymphoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.